Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (491-500 of 569) with videos related to

Pageof 57
Sort By:
Cancer Medicine|October 5, 2020
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerGrant M Fischer, Fernando C L Carapeto, Aron Y Joon, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Annals of Surgical Oncology|June 1, 2012
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)J Harrison Howard, John F Thompson, Nicola Mozzillo, et al.
Annals of Surgical Oncology|April 11, 2006
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional studySandra L Wong, Donald L Morton, John F Thompson, et al.
Human Molecular Genetics|January 7, 2021
Germline variants are associated with increased primary melanoma tumor thickness at diagnosisErnest Mangantig, Stuart MacGregor, Mark M Iles, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Nature Communications|May 22, 2019
LNK suppresses interferon signaling in melanomaLing-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
The Journal of Investigative Dermatology|September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic MelanomaAsmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Pageof 57

Showing results (491-500 of 569) with videos related to

Sort By:
Pageof 57
Cancer Medicine|October 5, 2020
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerGrant M Fischer, Fernando C L Carapeto, Aron Y Joon, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Annals of Surgical Oncology|June 1, 2012
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)J Harrison Howard, John F Thompson, Nicola Mozzillo, et al.
Annals of Surgical Oncology|April 11, 2006
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional studySandra L Wong, Donald L Morton, John F Thompson, et al.
Human Molecular Genetics|January 7, 2021
Germline variants are associated with increased primary melanoma tumor thickness at diagnosisErnest Mangantig, Stuart MacGregor, Mark M Iles, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Nature Communications|May 22, 2019
LNK suppresses interferon signaling in melanomaLing-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
The Journal of Investigative Dermatology|September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic MelanomaAsmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Pageof 57